•1 min read•from Science News
A drug may help people on GLP-1 meds preserve muscle
Our take
A clinical trial has shown that an experimental antibody can reduce lean‑mass loss in patients already receiving GLP‑1 medication, suggesting a potential strategy to preserve muscle during metabolic therapy. The study measured changes in body composition over 12 weeks, revealing a statistically significant attenuation of muscle wasting compared with placebo. While the impact on long‑term health outcomes remains to be determined, the findings underscore the importance of integrating novel biologics with existing pharmacotherapies.
In a clinical trial, an experimental antibody reduced lean-mass loss in people on a GLP-1 drug. Whether that improves health is unclear.
Read on the original site
Open the publisher's page for the full experience
Tagged with
#ecosystem health